¼¼°èÀÇ À̽ÄÇü ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀå
Implantable Drug Delivery Devices
»óǰÄÚµå : 1655462
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ À̽ÄÇü ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº 2030³â±îÁö ¹Ì±¹¿¡¼­ 412¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 289¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ À̽ÄÇü ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 412¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÇÇÀÓ¿ë ÀÓÇöõÆ®´Â CAGR 6.3%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 98¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ôÃß ÀÓÇöõÆ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 80¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ À̽ÄÇü ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀåÀº 2024³â¿¡ 80¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 64¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 5.7%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 5.8%¿Í 4.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ À̽ÄÇü ¾à¹°Àü´Þ µð¹ÙÀ̽º ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

À̽ÄÇü ¾à¹°Àü´Þ Àåºñ¶õ ¹«¾ùÀ̸ç, ¿Ö ÀÇ·á¿¡ º¯È­¸¦ ÃÊ·¡Çϴ°¡?

À̽ÄÇü ¾à¹°Àü´Þ Àåºñ´Â ü³»ÀÇ Æ¯Á¤ ºÎÀ§¿¡ Á÷Á¢ÀûÀ¸·Î Ç¥ÀûÈ­µÈ Àå±âÀûÀÎ ¾à¹° ¹æÃâÀ» À§ÇØ ¼³°èµÈ Ư¼öÇÑ ÀÇ·á¿ë ÀÓÇöõÆ®ÀÔ´Ï´Ù. ÀÌ Àåºñ´Â ƯÈ÷ ¾Ï, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼ºÁúȯ¿¡ ´ëÇØ ÀϰüµÇ°í Á¤È®ÇÑ Ä¡·á ¿ä¹ýÀ» °¡´ÉÄÉ ÇÔÀ¸·Î½á ÀÇ·á°è¿¡ º¯È­¸¦ °¡Á®´Ù ÁÙ ¼ö ÀÖ½À´Ï´Ù. Èí¼öÀ²ÀÌ ÀÏÁ¤ÇÏÁö ¾ÊÀº °æ±¸ ¹× ÁÖ»çÁ¦¿Í´Â ´Þ¸®, À̽ÄÇü µð¹ÙÀ̽º´Â ÀϰüµÈ ¾à¹° Åõ¿©¸¦ º¸ÀåÇϰí Ä¡·á È¿°ú¸¦ Çâ»ó½ÃŰ¸ç ºÎÀÛ¿ëÀ» ÁÙÀÔ´Ï´Ù. ¼ÒÈ­±â°üÀ» ¿ìȸÇÏ¿© Ç¥Àû Á¶Á÷¿¡ Á÷Á¢ ¾à¹°À» Àü´ÞÇÔÀ¸·Î½á º¹ÀâÇÑ Áúȯ¿¡ º¸´Ù È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇϸç, Á¤È®ÇÑ Åõ¿©°¡ Áß¿äÇÑ Á¾¾çÇÐ ¹× ³»ºÐºñÇÐ ºÐ¾ß¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô »ç¿ëµÉ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô À̽ÄÇü ¾à¹°Àü´Þ ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

»ýü Àç·á, ¸¶ÀÌÅ©·Î ÀüÀÚ°øÇÐ ¹× »ý¸í°øÇÐÀÇ ¹ßÀüÀ¸·Î À̽ÄÇü ¾à¹°Àü´Þ ÀåºñÀÇ ±â´É, ³»±¸¼º ¹× ¾ÈÀü¼ºÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÃֽŠÀåºñ´Â ÇöÀç »ýü ³»¿¡¼­ ½±°Ô ºÐÇØµÇÁö ¾Ê´Â »ýü ÀûÇÕ¼º Àç·á·Î ¸¸µé¾îÁ® Àå±âÀûÀÎ È¿´ÉÀ» º¸ÀåÇϰí ÀæÀº ±³Ã¼ Çʿ伺À» ÁÙÀÔ´Ï´Ù. ¹«¼± Á¦¾î ¹× ¸¶ÀÌÅ©·ÎÆßÇÁ ±â¼ú°ú °°Àº Çõ½ÅÀº ÇÁ·Î±×·¥ °¡´ÉÇϰí Á¶Àý °¡´ÉÇÑ ¾à¹° ¹æÃâÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ »óÅ º¯È­¿¡ µû¶ó ¿ë·®À» Á¶Á¤ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¶ÇÇÑ ÃÖ±Ù¿¡´Â ¾à¹°Àü´ÞÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ¼¾¼­¿Í Ä¿³ØÆ¼ºñƼ°¡ ³»ÀåµÈ ±â±âµéÀÌ µîÀåÇØ Àû½Ã¿¡ Á¶Á¤Çϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû µµ¾àÀ¸·Î ÀÎÇØ À̽ÄÇü ±â±âÀÇ Àû¿ë ¹üÀ§°¡ ³Ð¾îÁö°í, ´Ù¾çÇÑ º¹ÀâÇÑ °Ç°­ »óÅÂÀÇ Ä¡·á¿¡ °íµµ·Î ÀûÀÀÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¿Ö À̽ÄÇü ¾à¹°Àü´Þ Àåºñ°¡ ÀϹÝÈ­µÇ´Â°¡?

¸¸¼ºÁúȯ°ú »ýȰ½À°üº´ Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ º¸´Ù È¿À²ÀûÀÌ°í ´ú ħ½ÀÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó À̽ÄÇü ¾à¹°Àü´Þ Àåºñ´Â Çö´ë ÀÇ·á ºÐ¾ß¿¡¼­ ´õ¿í º¸ÆíÈ­µÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ¿Í ÀÇ·áÁøÀº ÀæÀº º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ¾ø¾Ö°í ó¹æµÈ ¿ä¹ýÀ» ´õ Àß ÁؼöÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ´Â ÀÌ·¯ÇÑ ±â±âÀÇ Æí¸®ÇÔ°ú ½Å·Ú¼º¿¡ Á¡Á¡ ´õ ¸Å·ÂÀ» ´À³¢°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃÖ¼Òħ½À ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÌ½Ä °úÁ¤ÀÌ ´õ ºü¸£°í ÅëÁõÀÌ Àû¾îÁö¸é¼­ º¸±ÞÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå±âÀûÀ̰í Áö¼ÓÀûÀÎ ¾à¹° Åõ¿©·ÎÀÇ ÀüȯÀº È¿°úÀûÀÎ Áúº´ °ü¸®¸¦ º¸ÀåÇϸ鼭 ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ ÃÊÁ¡À» ¸ÂÃá ÇコÄɾîÀÇ Å« È帧À» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

ÀÓÇöõÆ® ¾à¹°Àü´Þ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÃËÁø

ÀÓÇöõÆ® ¾à¹°Àü´Þ Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀü, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. »ýü Àç·á ¹× ¼ÒÇüÈ­ ±â¼úÀÇ Çõ½ÅÀ¸·Î ÀÎÇØ ½Å·ÚÇÒ ¼ö ÀÖ°í Á¦¾îµÈ ¾à¹° ¹æÃâÀ» Á¦°øÇÏ´Â ³»±¸¼º ÀÖ´Â ¼ÒÇü µð¹ÙÀ̽ºÀÇ °³¹ßÀÌ °¡´ÉÇØÁö¸é¼­ ¾Ï, È£¸£¸ó ºÒ±ÕÇü, ½Å°æÁúȯ µî ´Ù¾çÇÑ Áúȯ¿¡ ´ëÇÑ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Ç¥Àû Ä¡·á¿Í ¾à¹° »ýü ÀÌ¿ë·ü Çâ»ó¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭, ƯÈ÷ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ȯÀÚ Áß½ÉÀÇ Á¤¹Ð Ä¡·á·Î ÀüȯÇÏ´Â Ãß¼¼¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í ¼¼°è ÇコÄɾî ÁöÃâ Áõ°¡´Â ÀÌ·¯ÇÑ Ã·´Ü ±â±âÀÇ µµÀÔ ±âȸ¸¦ Áõ°¡½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(ÇÇÀÓ, ¾È°ú, ½ÉÀåÇ÷°ü, ´ç´¢º´, Á¾¾ç, ÀÚ°¡¸é¿ªÁúȯ, ±âŸ ¿ëµµ), Á¦Ç° À¯Çü(ÇÇÀÓ ÀÓÇöõÆ®, ôÃß ÀÓÇöõÆ®, ±ÙÁ¢Ä¡·á ½Ãµå, ¾àÁ¦¿ëÃ⽺ÅÙÆ®, »ýüÈí¼ö¼º ½ºÅÙÆ®, ¾È³» ÀÓÇöõÆ®, ÁÖÀÔ ÆßÇÁ, ±âŸ Á¦Ç° À¯Çü), ±â¼ú(È®»ê, ħÅõ¾Ð, ÀÚ±â, ±âŸ ±â¼ú), À¯Çü(»ýºÐÇØ¼º, ºñ»ýºÐÇØ¼º)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 46°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Implantable Drug Delivery Devices Market to Reach US$41.2 Billion by 2030

The global market for Implantable Drug Delivery Devices estimated at US$28.9 Billion in the year 2024, is expected to reach US$41.2 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Spinal Implants segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.0 Billion While China is Forecast to Grow at 5.7% CAGR

The Implantable Drug Delivery Devices market in the U.S. is estimated at US$8.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Implantable Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Implantable Drug Delivery Devices and Why Are They Transformative in Medicine?

Implantable drug delivery devices are specialized medical implants designed to provide targeted, controlled, and long-term drug release directly to specific areas within the body. These devices represent a transformative advancement in medicine, enabling treatment regimens that are both consistent and precise, particularly for chronic conditions like cancer, diabetes, and cardiovascular diseases. Unlike oral or injectable medications, which can vary in absorption rates, implantable devices ensure consistent drug dosing, improving treatment efficacy and reducing side effects. By bypassing the digestive system and delivering medication directly to target tissues, these devices offer a more effective solution for complex medical conditions, which is especially beneficial in oncology and endocrinology, where precise dosing is critical.

How Are Technological Advancements Shaping the Implantable Drug Delivery Market?

Advancements in biomaterials, microelectronics, and biotechnology have significantly enhanced the functionality, durability, and safety of implantable drug delivery devices. Modern devices are now made from biocompatible materials that resist degradation in the body, ensuring long-term efficacy and reducing the need for frequent replacements. Innovations such as wireless control and micro-pump technologies allow for programmable and adjustable drug release, enabling healthcare providers to tailor dosages based on a patient's evolving condition. Furthermore, some devices now incorporate sensors and connectivity features that enable real-time monitoring of drug delivery, allowing for timely adjustments and better patient outcomes. These technological breakthroughs are broadening the scope of implantable devices, making them highly adaptable for treating a range of complex health conditions.

Why Are Implantable Drug Delivery Devices Becoming More Commonplace?

The increasing prevalence of chronic and lifestyle-related diseases, along with a growing aging population, has driven demand for more efficient, less invasive treatment options, making implantable drug delivery devices more commonplace in modern healthcare. Patients and healthcare providers are increasingly drawn to the convenience and reliability of these devices, which eliminate the need for frequent hospital visits and enhance patient adherence to prescribed regimens. Additionally, advances in minimally invasive surgical techniques have made the implantation process quicker and less painful, further encouraging adoption. This shift toward long-term, continuous medication delivery reflects a larger trend in healthcare focused on improving patient quality of life while ensuring effective disease management.

The Growth in the Implantable Drug Delivery Devices Market Is Driven by Several Factors

The growth in the implantable drug delivery devices market is driven by several factors, including rapid technological advancements, rising prevalence of chronic diseases, and an increased focus on personalized medicine. Innovations in biomaterials and miniaturization technologies have allowed for the development of durable, compact devices that provide reliable, controlled drug release, expanding the application of these devices to conditions like cancer, hormonal imbalances, and neurological disorders. Growing demand for targeted therapies and improved drug bioavailability has fueled the adoption of these devices, particularly as healthcare shifts toward patient-centered, precision treatment. Additionally, the expansion of healthcare infrastructure in emerging markets and increased healthcare spending globally are creating more opportunities for the adoption of these advanced devices, further supporting market growth.

SCOPE OF STUDY:

The report analyzes the Implantable Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications); Product Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps, Other Product Types); Technology (Diffusion, Osmotic, Magnetic, Other Technologies); Type (Biodegradable, Non-biodegradable)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â